4- (3-Methyl-5-oxo-2-pyrazolin-1-yl) benzoic acid

4- (3-Methyl-5-oxo-2-pyrazolin-1-yl) benzoic acid has hypoglycaemic activity. 4- (3-Methyl-5-oxo-2-pyrazolin-1-yl) benzoic acid follows a mechanism based on the response to the oral glucose overcharge[1].

Product Specifications

CAS Number

[60875-16-3]

UNSPSC

12352005

Hazard Statement

H302

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/4-3-methyl-5-oxo-2-pyrazolin-1-yl-benzoic-acid.html

Purity

99.0

Solubility

10 mM in DMSO

Smiles

O=C(O)C1=CC=C(N2N=C(C)CC2=O)C=C1

Molecular Formula

C11H10N2O3

Molecular Weight

218.21

Precautions

H302

References & Citations

[1]G M Antón-Fos, et al. Pharmacological Studies of the Two New Hypoglycaemic Compounds 4- (3-methyl-5-oxo-2-pyrazolin-1-yl) benzoic Acid and 1- (mesitylen-2-sulfonyl) -1H-1,2,4-triazole. Arzneimittelforschung. 1994 Jul;44 (7) :821-6.